Three Independent Studies Include the ImmuKnow(R) Assay to Manage and Optimize Immunosuppression Therapy in Transplant Patients
...ant recipients to determine whether the use of the immuknow
assay to guide immunosuppression therapy would red...einer, the lead investigator in this study, "Using immuknow
in liver transplant recipients may help minimize r...nagement of immunosuppression therapy was based on immuknow
assay levels. In 32 other patients, changes in imm...
Living Donor Kidney Transplants Using Alemtuzumab Pre-Conditioning and Tacrolimus Monotherapy: Long-Term Safety and Efficacy
...antibody titers, donor-specific antibodies and the immuknow
assay beginning 6 months posttransplant and at 2-6...ee on tacrolimus monotherapy.
The use of the immuknow
assay as described in these studies has not been c...U.S. Food & Drug Administration.
An Independent Study Reports on the Utility of ImmuKnow(R), the Cylex(TM) Immune Cell Function Assay, for Monitoring Heart Transplant Recipients
...have contributed to defining the role of the Cylex immuknow
assay among recipients of solid organ transplants....cine followed 337 cardiac transplant patients with immuknow
to determine whether immuknow
assay values can be correlated with the incidence ...
Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea
...our support for a major, multi-center trial of the immuknow
for cell-mediated immunity at seven highly r...to be able to demonstrate the effectiveness
of the immuknow
assay in transplant populations of different ethni...nsortium of kidney
transplant centers will use the immuknow
assay to assess cell-mediated
immunity of 238 pati...
New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation
...ent number of patients to validate the role of the immuknow
in monitoring risk for organ rejection. The ...y support earlier
published data on the use of the immuknow
assay in monitoring adult
patients after a renal t...ransplant patients, and
the potential value of the immuknow
assay in monitoring immune status."
New Data Support Earlier Suggested Guidance for Levels of Cell-Mediated Immunity in Pediatric Liver Transplant Patients
...and his colleagues focused on
the use of the Cylex immuknow
assay to monitor cell-mediated immunity
post-trans...ents, cell-mediated immunity as measured using
assay is classified into three categories, as defi...>12 years of age.
-- During clinical quiescence, immuknow
assay results correlated with
clinical status of t...
University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
...togen-stimulated peripheral CD4+ T-cells using the immuknow
previously be shown to have utility in t...no, "In this study, we wanted to
learn whether the immuknow
test data correlated with data from other tests
terms of levels of ATP, were measured using the immuknow
categorized according to the tests label...
Penn State Hershey Transplant Program Uses Assay to Monitor Cell-Mediated Immunity
...urgery at Penn State Hershey Medical Center.
cell function test measures cell-mediated immunity...
340 ng ATP/ml (within the "moderate" range of the immuknow
for patients undergoing chemother...f their cancer.
"It is clear that we can use the immuknow
cell function assay to manage
Prospective Microbial Analysis of Bronchoalveolar Lavage Fluids with Immune Function Testing Can Distinguish Between Fungal Colonization and Fungal Disease In Lung Transplant Recipients
...unoreactivity, as measured
prospectively using the immuknow
assay of CMI, would be different for
patients with... preliminary results."
"Our study has shown that immuknow
values are significantly different
for patients wi...suppression
to prevent organ rejection. Results of immuknow
assays of CMI were included
in the analysis if and...
Independent Studies Report on Possible Roles for Cylex's Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
... Six different studies will report on use of immuknow
assay in presentations
at the annual meeting of...entations will report on
studies of the use of the immuknow
assay in a variety of heart and lung
transplant re...y, April 11 -- "Success of immune monitoring with immuknow
(Cylex) to assess rejection/infectious risk in...
New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection
COLUMBIA, Md., Feb. 20 /PRNewswire/ -- Cylex, Inc., today announced the
publication of an independent, peer reviewed, clinical research study in
which the level of cellular immune response measured prior to kidney
transplantation using the Company's proprietary ImmuKnow(R) immune cell
Serial Monitoring With ImmuKnow(R) is Useful in the Risk Assessment of Kidney Transplant Recipients
...sity of Miami , evaluated whether single or serial immuknow
assessments are most useful in determining rejecti...plant baseline readings and serial monitoring with immuknow
are crucial for posttransplant risk assessments. Our results suggest that an isolated immuknow
test is insufficient to aid in the management of p...
Cylex(TM) Receives ISO 13485:2003 and 9001:2000 Quality Certifications
supports the Company's plans to market its immuknow
immune cell function
assay to customers around the world.
is the immune cell function assay cleared by the F...d from CD4 cells
following cell stimulation.
test is a qualitative assay and does not directly ...
Immune Function in Adult Heart Transplant Patients Reflects Risk for Organ Rejection and Infection
"Based on our experience with the immuknow
assay we believe it is
possible to assess the prob...oring of adult heart transplant patients using
assay may have the potential to aid in the assessm...n was entitled, "Success of immune
monitoring with immuknow
(Cylex(TM)) to assess rejection/infectious risk in...
Cylex Announces Brad L. Stewart as President of the Company
...celerate understanding of the value of this technology in
specific therapeutic areas. We are also convinced that Cylex can rapidly
expand ex-US use of immuknow
to support patient care in many other
countries. This is an exciting challenge for me personally, and I will have
the backing of a talented team of pr...